Microglia activation state

Microglia are the primary resident immune cells of the central nervous system (CNS), responsible for maintaining neural homeostasis, synaptic pruning, and responding to injury or infection [1]. The term "Microglia activation state" describes the diverse functional and morphological transformations these cells undergo in response to pathological stimuli, moving from a homeostatic state to various reactive phenotypes [2]. While historically simplified into a binary M1 (pro-inflammatory) and M2 (anti-inflammatory) model, modern research recognizes a complex spectrum of activation, including specialized states like Disease-Associated Microglia (DAM) [3]. Dysregulation of these activation states is a central feature of neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, where chronic activation contributes to neurotoxicity and disease progression [4]. Therapeutic strategies aim to modulate these states—either by inhibiting pro-inflammatory pathways or enhancing neuroprotective functions—using agents like CSF1R inhibitors or TREM2 agonists [5]. Sources: [1] Colonna & Butovsky (2017) Ann Rev Immunol; [2] Wolf et al. (2017) Contemp Clin Neurosci; [3] Keren-Shaul et al. (2017) Cell; [4] Glass et al. (2010) Cell; [5] Ulland & Colonna (2018) Nat Rev Neurol.

Other names

Microglial activationMicroglial polarizationReactive microgliosisM1/M2 polarizationDisease-associated microglia (DAM)

Modulation of microglial phenotypes through receptor signaling (e.g., CSF1R, TREM2) or intracellular pathways (e.g., NF-κB) to shift cells from a neurotoxic to a neuroprotective or homeostatic state.